Literature DB >> 10346978

Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily.

E Thomassen1, B R Renshaw, J E Sims.   

Abstract

A novel member of the interleukin 1 receptor (IL-1R) superfamily, SIGIRR (single Ig IL-1R-related molecule) was identified in mouse and human. Although it shows the typical conserved motifs that characterize the IL-1R and Toll superfamily, it is structurally and functionally distinct from both. SIGIRR has only one Ig domain in its extracellular portion whereas the IL-1R family contains three Ig folds. An unusually long cytoplasmic domain is reminiscent of the structure of drosophila Toll, yet the SIGIRR peptide sequence is more closely related to IL-1RI. The human SIGIRR gene maps to 11p15. 5 and thus is not located in the same cluster on chromosome 2 that is known to contain four members of the IL-1R family. It failed to bind to the known IL-1-family members and, when co-expressed with the IL-1RI, had no effect on the binding of IL-1 and on subsequent nuclear factor kappaB (NFkappaB) activation. A chimera, in which the SIGIRR intracellular domain was fused to the IL-1R extracellular domain, did not activate NFkappaB unlike similar fusion proteins of other IL-1R related molecules. We conclude that the SIGIRR protein represents a novel subtype of the IL-1R superfamily. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346978     DOI: 10.1006/cyto.1998.0452

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  52 in total

1.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

3.  Nuclear factor-κB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome.

Authors:  Qin Yan; Ruaidhri J Carmody; Zhonghua Qu; Qingguo Ruan; Jennifer Jager; Shannon E Mullican; Mitchell A Lazar; Youhai H Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

4.  SIGIRR inhibits toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells.

Authors:  Chun Zhang; Xueling Wu; Yunfeng Zhao; Zhaoxia Deng; Guisheng Qian
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

Review 5.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells.

Authors:  Vibhudutta Awasthi; Prachi Vilekar; Geeta Rao; Shanjana Awasthi
Journal:  Immunobiology       Date:  2019-11-29       Impact factor: 3.144

Review 7.  Modulation of Toll-interleukin 1 receptor mediated signaling.

Authors:  Xiaoxia Li; Jinzhong Qin
Journal:  J Mol Med (Berl)       Date:  2005-01-21       Impact factor: 4.599

Review 8.  The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Authors:  Herve Boutin; Ian Kimber; Nancy J Rothwell; Emmanuel Pinteaux
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

9.  Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.

Authors:  Manisha Yadav; Jingyao Zhang; Hans Fischer; Wen Huang; Nataliya Lutay; Christine Cirl; Josephine Lum; Thomas Miethke; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

10.  Biomarkers in SIRS and sepsis: Quo vadis?

Authors:  Alexander R Novotny
Journal:  J Emerg Trauma Shock       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.